LCM
YARW

Lynx1 Capital Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Lynx1 Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$973K Buy
+32,574
New +$950K 0.15% 17
2024
Q4 		– Sell
-324
Closed -$30.4K – 23
2024
Q3 		$30.4K Hold
324
– – 0.01% 18
2024
Q2 		$31.9K Buy
+324
New +$40.4K 0.01% 17

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Lynx1 Capital Management's YARW Position: Q1 2026 in Review

Lynx1 Capital Management opened a new position in Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2026: 32,574 shares worth $973K. The stake represents 0.15% of the portfolio and ranks #17 among its holdings. This is a return to the name: Lynx1 Capital Management previously reported a position in YARW as recently as Q3 2024.

Lynx1 Capital Management first reported a position in YARW in Q2 2024 and has held it in 3 quarters since. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Lynx1 Capital Management held 32,574 shares of Yarrow Bioscience, Inc. Common Stock worth $973K as of Q1 2026.
  • Yarrow Bioscience, Inc. Common Stock was a new Lynx1 Capital Management position in Q1 2026.
  • Yarrow Bioscience, Inc. Common Stock made up 0.15% of Lynx1 Capital Management's portfolio in Q1 2026, its #17 holding.
  • Lynx1 Capital Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2024 and has held it in 3 quarters since.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Lynx1 Capital Management's 13F filing for Q1 2026, filed 4 May 2026.